Euglycaemic diabetic ketosis decompensation under dapagliflozin in a patient with MODY3

Diabetes Metab. 2021 Nov;47(6):101248. doi: 10.1016/j.diabet.2021.101248. Epub 2021 Mar 14.
No abstract available

Publication types

  • Letter

MeSH terms

  • Benzhydryl Compounds / therapeutic use
  • Blood Glucose
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetic Ketoacidosis* / drug therapy
  • Glucosides / therapeutic use
  • Humans

Substances

  • Benzhydryl Compounds
  • Blood Glucose
  • Glucosides
  • dapagliflozin

Supplementary concepts

  • Maturity-Onset Diabetes of the Young, Type 3